Veru Inc.
VERU Nasdaq· Pharmaceutical Preparations
Last close · Oct 26, 2026
$2.21
KIRA · Stoqly’s AI analyst, in plain words
- Veru Inc. lost $22.7M in fiscal 2025.
- Free cash flow was −$30.0M in fiscal 2025, — of revenue.
Market cap
—
P/E
—
Revenue
—
Net income
−$22.7M
Free cash flow
−$30.0M
Operating margin
—
Veru Inc. in 30 seconds · fiscal 2025
Does it make a profit?
−$22.7M
No. It lost money last year.
What Veru Inc. does
No business description yet.
- Fiscal year ends
- September 30, 2025
- Latest annual report
- 10-K · Dec 17, 2025
- Legal name
- VERU INC.
- CIK
- 0000863894
Veru Inc. · VERU
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $61.3M | $39.4M | $16.3M | $16.9M | — |
| Revenue growth | 43.8% | −35.8% | −58.6% | 3.6% | — |
| Gross margin | 78.2% | 77.7% | 46.4% | 34.7% | — |
| Operating margin | 21.2% | −212.1% | −575.5% | −214.2% | — |
| Net income | $7.4M | −$84.0M | −$93.2M | −$37.8M | −$22.7M |
| Net margin | 12.1% | −213.5% | −571.6% | −223.9% | — |
| Diluted EPS | $0.09 | −$1.05 | −$1.10 | — | — |
| Cash | |||||
| Cash from operations | −$15.6M | −$47.5M | −$88.0M | −$21.7M | −$30.0M |
| Capital expenditure | $0.4M | $0.7M | $0.7M | $0.2M | $0.0M |
| Free cash flow | −$15.9M | −$48.2M | −$88.7M | −$21.8M | −$30.0M |
| FCF margin | −26.0% | −122.6% | −544.1% | −129.3% | — |
| Share count change | 25.5% | −4.4% | 6.1% | — | — |
| Debt and strength | |||||
| Cash and short-term investments | — | — | $9.6M | $24.9M | $15.8M |
| Shareholders' equity | $155M | $82.8M | $19.7M | $32.3M | $18.3M |
| Current ratio | 9.6x | 2.7x | 1.3x | 3.0x | 2.4x |
| Interest coverage | 2.7x | −19.1x | −38.6x | −59.5x | — |
| Returns and quality | |||||
| Return on equity | 8.0% | −70.8% | −181.8% | −145.4% | −89.7% |
| Return on tangible equity | 5.1% | −116.8% | −728.1% | −148.6% | −198.4% |
| Piotroski F-score | 4 | 2 | 2 | 3 | — |
| Altman Z'' | 10.3 | −3.3 | −28.0 | −16.2 | −36.1 |
Insiders bought, 12 months
$0.0M
1 insider
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Veru Inc. · VERU
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $2.21 a share, the company is worth —.
Source: SEC EDGAR XBRL filings (CIK 0000863894). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.